ArticleMedicine2025
Treatment of intra-bony defect and periodontal phenotype modification therapy (PhMT): A one-year follow-up case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleThe treatment of a patient with an intrabony defect using periodontal phenotype modification therapy (PhMT) is alternative approach in correcting intrabony defects and changing periodontal phenotypes. PATIENT CONCERNS: A 27-year-old male patient arrived with a severe intrabony defect and a poor periodontal phenotype. The patient received PhMT, which includes nonsurgical periodontal therapy, bone grafting, and orthodontic treatment. After 1 year, there were considerable changes in the intrabony defect, periodontal phenotype, and general oral health. DIAGNOSES: A 27-year-old male patient had a profound intrabony defect (10 mm) and a poor periodontal phenotype (thin gingiva, high frenum attachment).
interventionsThe patient received PhMT, which includes nonsurgical periodontal therapy (scaling and root planing), bone grafting (allograft), and orthodontic treatment (correcting tooth placement). After 1 year, there were considerable improvements: Intrabony defect reduction (from 10 to 3 mm), improved periodontal phenotype (thickened gingiva, decreased frenum attachment), and improved dental health (lower pocket depths, increased attachment levels). PhMT successfully repaired the intrabony deficiency and altered the patient's periodontal phenotype. OUTCOMES: Improved dental health and aesthetics were the result of the comprehensive treatment, which addressed the problem as well as the patient's underlying periodontal features. LESSONS: The efficacy of PhMT in correcting intrabony abnormalities and altering periodontal phenotypes is demonstrated in this case study. This strategy presents a viable remedy for patients with intricate periodontal requirements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.